questionsmedicales.fr
Phénomènes biologiques
Évolution biologique
Isolement reproductif
Isolement reproductif : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Isolement reproductif : Questions médicales les plus fréquentes",
"headline": "Isolement reproductif : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Isolement reproductif : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-28",
"dateModified": "2025-03-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Isolement reproductif"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Évolution biologique",
"url": "https://questionsmedicales.fr/mesh/D005075",
"about": {
"@type": "MedicalCondition",
"name": "Évolution biologique",
"code": {
"@type": "MedicalCode",
"code": "D005075",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G16.075"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Isolement reproductif",
"alternateName": "Reproductive Isolation",
"code": {
"@type": "MedicalCode",
"code": "D060047",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Maria R Servedio",
"url": "https://questionsmedicales.fr/author/Maria%20R%20Servedio",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology, University of North Carolina, Chapel Hill, North Carolina, 27599."
}
},
{
"@type": "Person",
"name": "Jian Wang",
"url": "https://questionsmedicales.fr/author/Jian%20Wang",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Crop Gene Resources and Breeding, Institute of Crop Sciences, Chinese Academy of Agricultural Sciences, Beijing 100081, China."
}
},
{
"@type": "Person",
"name": "Zhigang Zhao",
"url": "https://questionsmedicales.fr/author/Zhigang%20Zhao",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Crop Genetics & Germplasm Enhancement and Utilization, Nanjing Agricultural University, Nanjing 210095, China."
}
},
{
"@type": "Person",
"name": "Xiaowen Yu",
"url": "https://questionsmedicales.fr/author/Xiaowen%20Yu",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Crop Genetics & Germplasm Enhancement and Utilization, Nanjing Agricultural University, Nanjing 210095, China."
}
},
{
"@type": "Person",
"name": "Jianmin Wan",
"url": "https://questionsmedicales.fr/author/Jianmin%20Wan",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Crop Genetics & Germplasm Enhancement and Utilization, Nanjing Agricultural University, Nanjing 210095, China; State Key Laboratory of Crop Gene Resources and Breeding, Institute of Crop Sciences, Chinese Academy of Agricultural Sciences, Beijing 100081, China. Electronic address: wanjianmin@caas.cn."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Synergism of the receptor tyrosine kinase Axl with ErbB receptors mediates resistance to regorafenib in hepatocellular carcinoma.",
"datePublished": "2023-09-08",
"url": "https://questionsmedicales.fr/article/37746265",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fonc.2023.1238883"
}
},
{
"@type": "ScholarlyArticle",
"name": "The miR-429 suppresses proliferation and migration in glioblastoma cells and induces cell-cycle arrest and apoptosis via modulating several target genes of ERBB signaling pathway.",
"datePublished": "2022-10-11",
"url": "https://questionsmedicales.fr/article/36219319",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11033-022-07903-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Protocol for identifying properties of ERBB receptor antagonists using the barcoded ERBBprofiler assay.",
"datePublished": "2024-04-16",
"url": "https://questionsmedicales.fr/article/38635397",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.xpro.2024.102987"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mechanisms and therapeutic targets of ErbB family receptors in hepatocellular carcinoma: a narrative review.",
"datePublished": "2024-06-27",
"url": "https://questionsmedicales.fr/article/38988928",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.21037/tcr-24-837"
}
},
{
"@type": "ScholarlyArticle",
"name": "A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation.",
"datePublished": "2023-06-14",
"url": "https://questionsmedicales.fr/article/37314501",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00280-023-04545-4"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes biologiques",
"item": "https://questionsmedicales.fr/mesh/D001686"
},
{
"@type": "ListItem",
"position": 3,
"name": "Évolution biologique",
"item": "https://questionsmedicales.fr/mesh/D005075"
},
{
"@type": "ListItem",
"position": 4,
"name": "Isolement reproductif",
"item": "https://questionsmedicales.fr/mesh/D060047"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Isolement reproductif - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Isolement reproductif",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Isolement reproductif",
"description": "Comment identifier l'isolement reproductif ?\nQuels tests génétiques sont utilisés ?\nL'observation comportementale est-elle suffisante ?\nQuels signes indiquent un isolement ?\nPeut-on utiliser des modèles mathématiques ?",
"url": "https://questionsmedicales.fr/mesh/D060047?mesh_terms=ErbB+Receptors&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Isolement reproductif",
"description": "Quels symptômes indiquent un isolement reproductif ?\nLes hybrides sont-ils un symptôme ?\nComment les comportements de cour changent-ils ?\nY a-t-il des signes de stress chez les espèces ?\nLes changements environnementaux affectent-ils les symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D060047?mesh_terms=ErbB+Receptors&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Isolement reproductif",
"description": "Comment prévenir l'isolement reproductif ?\nLes corridors écologiques aident-ils ?\nL'éducation des communautés est-elle importante ?\nLes lois de protection des espèces sont-elles efficaces ?\nComment la recherche contribue-t-elle à la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D060047?mesh_terms=ErbB+Receptors&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Isolement reproductif",
"description": "Peut-on traiter l'isolement reproductif ?\nComment favoriser la reproduction entre espèces ?\nLes techniques de reproduction assistée sont-elles utiles ?\nLes croisements contrôlés sont-ils efficaces ?\nY a-t-il des traitements hormonaux possibles ?",
"url": "https://questionsmedicales.fr/mesh/D060047?mesh_terms=ErbB+Receptors&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Isolement reproductif",
"description": "Quelles complications peuvent résulter de l'isolement ?\nL'isolement reproductif affecte-t-il la survie des espèces ?\nY a-t-il des impacts sur l'écosystème ?\nLes espèces envahissantes aggravent-elles l'isolement ?\nComment l'isolement influence-t-il l'évolution ?",
"url": "https://questionsmedicales.fr/mesh/D060047?mesh_terms=ErbB+Receptors&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Isolement reproductif",
"description": "Quels facteurs augmentent le risque d'isolement ?\nLes changements climatiques sont-ils un facteur ?\nL'urbanisation influence-t-elle l'isolement ?\nLes pratiques agricoles affectent-elles l'isolement ?\nLes maladies peuvent-elles être un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D060047?mesh_terms=ErbB+Receptors&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier l'isolement reproductif ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'isolement reproductif se diagnostique par l'observation de comportements de reproduction et de compatibilité génétique."
}
},
{
"@type": "Question",
"name": "Quels tests génétiques sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de compatibilité génétique, comme les analyses d'ADN, peuvent être effectués."
}
},
{
"@type": "Question",
"name": "L'observation comportementale est-elle suffisante ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'observation des comportements de cour et de reproduction peut suffire pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un isolement ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des différences dans les rituels de cour ou l'incapacité à produire une descendance viable sont des signes."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des modèles mathématiques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des modèles mathématiques peuvent aider à prédire les résultats de l'isolement reproductif."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un isolement reproductif ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent l'absence de reproduction entre populations et des comportements de cour inappropriés."
}
},
{
"@type": "Question",
"name": "Les hybrides sont-ils un symptôme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la présence d'hybrides stériles peut indiquer un isolement reproductif entre espèces."
}
},
{
"@type": "Question",
"name": "Comment les comportements de cour changent-ils ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les comportements de cour peuvent devenir moins attractifs ou inappropriés entre espèces isolées."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes de stress chez les espèces ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut se manifester par des comportements anormaux lors des interactions reproductives."
}
},
{
"@type": "Question",
"name": "Les changements environnementaux affectent-ils les symptômes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les changements environnementaux peuvent exacerber les symptômes d'isolement reproductif."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'isolement reproductif ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La préservation des habitats et la gestion des populations sont essentielles pour prévenir l'isolement."
}
},
{
"@type": "Question",
"name": "Les corridors écologiques aident-ils ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les corridors écologiques facilitent les échanges entre populations et réduisent l'isolement."
}
},
{
"@type": "Question",
"name": "L'éducation des communautés est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sensibiliser les communautés à la biodiversité aide à prévenir l'isolement reproductif."
}
},
{
"@type": "Question",
"name": "Les lois de protection des espèces sont-elles efficaces ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des lois strictes peuvent protéger les espèces et réduire les risques d'isolement."
}
},
{
"@type": "Question",
"name": "Comment la recherche contribue-t-elle à la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "La recherche aide à comprendre les mécanismes d'isolement et à développer des stratégies de conservation."
}
},
{
"@type": "Question",
"name": "Peut-on traiter l'isolement reproductif ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement direct, mais des interventions peuvent favoriser la reproduction."
}
},
{
"@type": "Question",
"name": "Comment favoriser la reproduction entre espèces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des programmes de conservation et de gestion des habitats peuvent aider à favoriser la reproduction."
}
},
{
"@type": "Question",
"name": "Les techniques de reproduction assistée sont-elles utiles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la reproduction assistée peut aider à surmonter certains obstacles à la reproduction."
}
},
{
"@type": "Question",
"name": "Les croisements contrôlés sont-ils efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les croisements contrôlés peuvent être utilisés pour étudier et potentiellement réduire l'isolement."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements hormonaux possibles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements hormonaux peuvent être envisagés pour stimuler la reproduction chez certaines espèces."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent résulter de l'isolement ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'isolement peut entraîner une perte de diversité génétique et une vulnérabilité accrue aux maladies."
}
},
{
"@type": "Question",
"name": "L'isolement reproductif affecte-t-il la survie des espèces ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'isolement peut réduire la capacité d'adaptation des espèces, menaçant leur survie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des impacts sur l'écosystème ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'isolement reproductif peut perturber les interactions écologiques et l'équilibre des écosystèmes."
}
},
{
"@type": "Question",
"name": "Les espèces envahissantes aggravent-elles l'isolement ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les espèces envahissantes peuvent exacerber l'isolement en compétition pour les ressources."
}
},
{
"@type": "Question",
"name": "Comment l'isolement influence-t-il l'évolution ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'isolement reproductif peut conduire à la spéciation, influençant ainsi le cours de l'évolution."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'isolement ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "La fragmentation des habitats et la perte de biodiversité augmentent le risque d'isolement."
}
},
{
"@type": "Question",
"name": "Les changements climatiques sont-ils un facteur ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les changements climatiques peuvent modifier les habitats et accroître l'isolement reproductif."
}
},
{
"@type": "Question",
"name": "L'urbanisation influence-t-elle l'isolement ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'urbanisation peut fragmenter les habitats et limiter les interactions entre populations."
}
},
{
"@type": "Question",
"name": "Les pratiques agricoles affectent-elles l'isolement ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les pratiques agricoles intensives peuvent réduire les habitats et favoriser l'isolement."
}
},
{
"@type": "Question",
"name": "Les maladies peuvent-elles être un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les épidémies peuvent réduire les populations et augmenter l'isolement reproductif."
}
}
]
}
]
}
Hepatocellular carcinoma (HCC) patients at advanced stages receive immunotherapy or treatment with tyrosine kinase inhibitors (TKIs) such as Sorafenib (Sora) or Lenvatinib in frontline as well as Rego...
In this study, we addressed the impact of the receptor tyrosine kinase Axl binding to its ligand Gas6 in acquiring refractoriness to TKIs. The initial responses of Axl-positive and Axl-negative cell l...
We show that HCC cells exhibiting a mesenchymal-like phenotype were less sensitive to drug treatment, linking TKI resistance to changes in epithelial plasticity. Gas6/Axl expression and activation wer...
Together, these data suggest that the inhibition of ErbBs is synthetic lethal with Rego in Axl-expressing HCC cells, showing a novel vulnerability of HCC....
Glioblastoma multiforme (GBM) is an aggressive and lethal brain cancer, which is incurable with standard cancer treatments. miRNAs have great potential to be used for gene therapy due to their ability...
Here, miR-429 was overexpressed using lentiviral vectors in U-251 and U-87 GBM cells and it was observed that the expression level of several oncogenes of the ERBB pathway, EGFR, PIK3CA, PIK3CB, KRAS,...
Altogether, miR-429 seems to be an efficient suppressor of the ERBB genetic signaling pathway and a potential therapeutic for GBM....
The ERBBprofiler assay measures compound effects on ERBB family receptors and key downstream signaling pathways that are implicated in cancer or other complex diseases. Here, we present a protocol for...
Hepatocellular carcinoma (HCC) is a highly heterogeneous and aggressive tumor. In recent years, the incidence of HCC has been increasing worldwide. Despite notable advancements in treatment methodolog...
We performed a comprehensive, narrative review of the latest literature to define the current progress of ErbB family receptors in HCC in both the pre-clinical and clinical arenas....
The ErbB family belongs to the tyrosine kinase (TK) receptor family that comprises four members. These members are closely associated with proliferation, cell cycle regulation, and migration during HC...
Through in-depth research and the application of ErbB-targeted therapy, broader avenues will be opened for the treatment of HCC and other tumors, leading to more personalized and precise treatment app...
Aberrant alterations of ERBB receptor tyrosine kinases lead to tumorigenesis. Single agent therapy targeting EGFR or HER2 has shown clinical successes, but drug resistance often develops due to aberra...
Patients with actionable somatic mutations or amplifications in ERBB genes or actionable KRAS mutations were enrolled to receive neratinib and trametinib in this phase I dose escalation trial. The pri...
Twenty patients were enrolled with a median age of 50.5 years and a median of 3 lines of prior therapy. Grade 3 treatment-related toxicities included: diarrhea (25%), vomiting (10%), nausea (5%), fati...
Neratinib and trametinib combination was toxic and had limited clinical efficacy. This may be due to suboptimal drug dosing given drug-drug interactions....
NCT03065387....
ERBB receptor tyrosine kinases are involved in development and diseases like cancer, cardiovascular, neurodevelopmental, and mental disorders. Although existing drugs target ERBB receptors, the next g...
Gallbladder cancer (GBC) is an aggressive type of digestive system cancer with a dismal outcome. Given the lack of effective treatment options, the disease rapidly reoccurs and 5-year survival rate is...
We conduct a multicentre and randomised study on afatinib combined with gemcitabine and oxaliplatin (GEMOX) in patients with ErbB pathway mutated GBC. Clinical and biological evaluation involving ErbB...
The study was approved by the medical-ethical review committee of Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine and Renji Hospital Affiliated to Shanghai Jiao Tong Uni...
NCT04183712....
Epidermal growth factor receptor (EGFR), which is referred to as ErbB1/HER1, is the prototype of the EGFR family of receptor tyrosine kinases which also comprises ErbB2 (Neu, HER2), ErbB3 (HER3), and ...
Current therapies targeting the human epidermal growth factor receptor (HER) family, including monoclonal antibodies (mAbs) and tyrosine kinase inhibitors (TKIs), are limited by drug resistance and sy...
Transactivation of epidermal growth factor receptors (EGFR) provides intricate control over multiple regulatory cellular processes that merge the diversity of G protein-coupled receptors (GPCRs) with ...